SULFADIAZINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where SULFADIAZINE was used for Psoriasis.
Most Reported Side Effects for SULFADIAZINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 228 | 26.9% | 4 | 22 |
| Condition aggravated | 122 | 14.4% | 44 | 82 |
| Dyspnoea | 115 | 13.6% | 37 | 64 |
| Therapeutic product effect incomplete | 101 | 11.9% | 35 | 62 |
| Neurological symptom | 96 | 11.3% | 37 | 64 |
| Pain in extremity | 95 | 11.2% | 36 | 63 |
| Pulmonary fibrosis | 95 | 11.2% | 37 | 63 |
| Asthma | 94 | 11.1% | 37 | 63 |
| Pulmonary alveolar haemorrhage | 94 | 11.1% | 37 | 62 |
| Haemoptysis | 93 | 11.0% | 37 | 62 |
| Lung disorder | 93 | 11.0% | 37 | 62 |
| Neuritis | 93 | 11.0% | 37 | 62 |
| Obstructive airways disorder | 93 | 11.0% | 37 | 62 |
| Pulmonary vasculitis | 93 | 11.0% | 36 | 61 |
| Anxiety | 92 | 10.9% | 37 | 60 |
Other Indications for SULFADIAZINE
Product used for unknown indication (392)
Cerebral toxoplasmosis (96)
Toxoplasmosis (78)
Ill-defined disorder (27)
Rheumatoid arthritis (22)
Eye infection toxoplasmal (19)
Acanthamoeba infection (16)
Pneumonia (13)
Congenital toxoplasmosis (12)
Prophylaxis (11)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)